log(TG)/HDL-C is related to both residual cardiometabolic risk and β-cell function loss in type 2 diabetes males.

Statin and fibrate were given to 54 and 21% of the whole cohort, with a significant trend for increased fibrate use across quintiles, from 9% (Q I) to 46% (Q V) (p < 0.0001; Table 1 ).

also in 9,775 other papers